LM-168

DRUG2 trials

Sponsors

LaNova Medicines Limited

Conditions

Advanced Solid TumorAdvanced Solid Tumours

Phase 1

A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours

RecruitingNCT06868199

LaNova Medicines LimitedAdvanced Solid Tumours

Start: 2025-05-06End: 2028-02-01Target: 87Updated: 2025-09-12

Phase 2

A Study of LM-168 Combined With Other Anti-tumor Treatments in Participants With Advanced Solid Tumors

RecruitingNCT07669415

LaNova Medicines LimitedAdvanced Solid Tumor

Start: 2026-07-29End: 2028-12-15Target: 108Updated: 2026-07-30